Compass Therapeutics Inc. <CMPX.O>: Guggenheim cuts target price to $4 from $8
CMPX•Related News
Acadia Healthcare Company, Inc. <ACHC.O>: Leerink Partners raises target price to $33 from $30
ACHC•
Ozempic-Maker Novo Open To Upgrading Us Listing
NVO•
UiPath Inc <PATH.N>: RBC cuts target price to $15 from $17
PATH•
Global markets-Asia stocks ride tech wave higher, oil stays subdued
SPY•
Amgen Inc <AMGN.O>: Jefferies raises target price to $410 from $367
AMGN•